Description
A retinoid prodrug of tazarotenic acid; inhibits proliferation and collagen synthesis by human dermal fibroblasts (1 μM); downregulates markers of keratinocyte differentiation, keratinocyte proliferation, and inflammation and upregulates TIG1 and TIG2 in human-derived psoriatic lesions following topical administration; induces complete reduction of skin utricle diameter in the Rhino mouse (0.1% per day, topical); decreases basal cell carcinoma number and size in a Ptch1+/- mouse model of ultraviolet- or ionizing radiation-induced skin cancer when (0.1% per day, topical)
Formal name: 6-[2-(3,4-dihydro-4,4-dimethyl-2H-1-benzothiopyran-6-yl)ethynyl]-3-pyridinecarboxylic acid, ethyl ester
Synonyms: AGN 190168
Molecular weight: 351.5
CAS: 118292-40-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Immunology & Inflammation|Autoimmunity